More
    Guided Solutions - Connecting Talent With Innovation/div>

    Adagio Medical reports findings from ventricular tachycardia study

    Adagio Medical has reported preliminary acute efficacy and safety findings from its FULCRUM-VT Study, assessing the use of Ultralow Temperature Cryoablation (ULTC) for treating sustained monomorphic ventricular tachycardia (SMVT) in individuals with ischemic and...

    Adagio Medical reports findings from ventricular tachycardia study

    Adagio Medical has reported preliminary acute efficacy and safety findings from its FULCRUM-VT Study, assessing the use of Ultralow Temperature Cryoablation (ULTC) for treating...

    FDA grants 510(k) clearance to Surgical Theater’s spine platform

    The US Food and Drug Administration (FDA) has granted 510(k) clearance to Surgical Theater’s next-generation platform, SyncAR Spine. The decision enhances the platform’s suite of...

    Monteris and Symphony partner on laser ablation platform

    Monteris Medical and Symphony Robotics have entered a strategic collaboration aimed at enhancing precision in laser ablation procedures for complex brain tumours. Under the partnership,...

    Inspire Medical reports positive Inspire V therapy results

    Inspire Medical announced clinical outcomes data for its latest-generation Inspire V neuromodulation system. The Minneapolis-based company reported outcomes from a clinical study in Singapore and its...
    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    Finance

    Funding

    Clinical Trials

    Adagio Medical reports findings from ventricular tachycardia study

    Adagio Medical has reported preliminary acute efficacy and safety findings from its FULCRUM-VT Study, assessing the use of Ultralow Temperature Cryoablation (ULTC) for treating...

    Inspire Medical reports positive Inspire V therapy results

    Inspire Medical announced clinical outcomes data for its latest-generation Inspire V neuromodulation system. The Minneapolis-based company reported outcomes from a clinical study in Singapore and its...

    Pulse Biosciences shares strong first-in-human PFA data

    Pulse Biosciences announced clinical study results from a first-in-human study of its nPulse system. The company shared findings from the first-in-human feasibility study of the...

    ACORAI has positive results in heart failure management platform study

    Acorai, a clinical-stage company pioneering non-invasive hemodynamic monitoring for heart failure management, this week announced topline results from the 1,600-patient CAPTURE-HF study (Machine-Learning Estimation...

    Innovation

    Regulatory Approvals

    Adagio Medical reports findings from ventricular tachycardia study

    Adagio Medical has reported preliminary acute efficacy and safety findings from its FULCRUM-VT Study, assessing the use of Ultralow Temperature Cryoablation (ULTC) for treating...

    FDA grants 510(k) clearance to Surgical Theater’s spine platform

    The US Food and Drug Administration (FDA) has granted 510(k) clearance to Surgical Theater’s next-generation platform, SyncAR Spine. The decision enhances the platform’s suite of...

    Monteris and Symphony partner on laser ablation platform

    Monteris Medical and Symphony Robotics have entered a strategic collaboration aimed at enhancing precision in laser ablation procedures for complex brain tumours. Under the partnership,...

    Inspire Medical reports positive Inspire V therapy results

    Inspire Medical announced clinical outcomes data for its latest-generation Inspire V neuromodulation system. The Minneapolis-based company reported outcomes from a clinical study in Singapore and its...

    M&A

    Archives

    Latest articles